Cell-mediated cytotoxicity in chronic active liver disease: a new test system.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.5555/uri:pii:0016508578901476PMID 565311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification and characterization of human liver-specific membrane lipoprotein (LSP).

  1977cited by this paper
• Temporary inhibition of antibody-dependent, cell-mediated cytotoxicity by pretreatment of human attacking cells with ammonium chloride.

  1976cited by this paper
• Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.

  1976cited by this paper
• Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.

  1976cited by this paper
• Chronic hepatitis--a perspective on classification and determinants of prognosis.

  1976cited by this paper
• F-antigen: nature, liver specificity, and release in experimental liver injury.

  1976cited by this paper
• Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

  1976cited by this paper
• Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.

  1976cited by this paper
• Two immunologic reactions in the pathogenesis of hepatitis?

  1976cited by this paper
• In vitro studies of inflammatory bowel disease. Surface receptors of the mononuclear cell required to lyse allogeneic colonic epithelial cells.

  1976cited by this paper
• Immunological factors in the evolution of active chronic hepatitis and other autoimmune liver diseases.

  1975cited by this paper
• Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

  1975cited by this paper
• Immunopathological aspects of hepatitis type B.

  1975cited by this paper
• Cell-mediated immunity in acute and chronic hepatitis.

  1975cited by this paper
• Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.

  1975cited by this paper
• Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis.

  1975cited by this paper
• Inhibition of macrophage migration in response to hepatitis Bs antigen.

  1975cited by this paper
• Immunological aspects of hepatitis B virus infection.

  1975cited by this paper
• Chronic hepatitis.

  1974cited by this paper
• Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis

  1974cited by this paper
• Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

  1974cited by this paper
• FUNCTIONAL CHARACTERISTICS OF PEYER'S PATCH LYMPHOID CELLS

  1974cited by this paper
• Chronic active liver disease reexamined: prognosis hopeful.

  1974cited by this paper
• Histocompatibility Antigens in Active Chronic Hepatitis and Primary Biliary Cirrhosis

  1974cited by this paper
• On the mechanism of T-cell mediated cytolysis.

  1973cited by this paper
• Cell-mediated Immune Responses in Chronic Liver Diseases

  1972cited by this paper
• Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

  1972cited by this paper
• Liver specific antigens. Purification and characterization.

  1972cited by this paper
• Association of autoimmune active chronic hepatitis with HL-A1,8.

  1972cited by this paper
• Cell-mediated immune reactivity in liver disease

  1972cited by this paper
• Chronic hepatitis--migration inhibition of leukocytes in the presence of Australia antigen.

  1972cited by this paper
• Relation between Australia antigen and autoimmune hepatitis.

  1972cited by this paper
• Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

  1972cited by this paper
• Lymphocyte transformation by Australia antigen.

  1971cited by this paper
• Active chronic hepatitis.

  1970cited by this paper
• Australia antigen in acute and chronic liver disease.

  1969cited by this paper
• Inhibition of in vitro cytotoxicity of lymphocytes from patients with ulcerative colitis and granulomatous colitis for allogeneic colonic epithelial cells using horse anti-human thymus serum.

  1968cited by this paper

• Participation of the cholestatic factor in the pathogenesis of intrahepatic cholestasis, found in various liver diseases

  2007cites this paper
• Studies on the mechanism of liver injury by antibody-dependent cell-mediated cytotoxicity (ADCC)—partial purification of cytotoxic factor detected in the culture supernatant of ADCC reaction

  2007cites this paper
• Chronic active hepatitis

  2006cites this paper
• Liver and biliary Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis

  2006cites this paper
• Preventive effect of gamma-glutamylcysteinylethyl ester on immunological cell injury in isolated rat hepatocytes with anti-rat liver plasma membrane antiserum treatment.

  1993cites this paper
• Hepatitis B virus-DNA transfected myeloma cell-specific cytotoxic T cells in chronic hepatitis B patients.

  1992cites this paper
• Chronic active hepatitis.

  1991cites this paper
• The Asialoglycoprotein Receptor as Target Structure in Autoimmune Liver Diseases

  1991cites this paper
• Retroviral-mediated transfer and expression of hepatitis B e antigen in human primary skin fibroblasts and Epstein-Barr virus-transformed B lymphocytes.

  1989cites this paper
• Analysis of liver‐specific protein LSP using murine monoclonal antibodies

  1987cites this paper
• [In vitro tests in the diagnosis of drug hepatitis].

  1987cites this paper
• Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitro.

  1987cites this paper
• T lymphocyte subsets implicated in cytotoxicity in autologous hepatocytes in chronic active hepatitis patients with active viral replication.

  1986cites this paper
• Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders.

  1986cites this paper
• Naturally occurring serum antiidiotypic antibody against antiliver‐specific membrane lipoprotein in patients with hepatitis

  1985cites this paper
• Possible participation of cholestatic factor in the pathogenesis of intrahepatic cholestasis in alcoholic liver disease.

  1985cites this paper
• Study of cellular immunity in experimental autoimmune hepatitis in mice: transfer of spleen cells sensitized with liver proteins.

  1985cites this paper
• Multiple systems organ failure. Modulation of hepatocyte protein synthesis by endotoxin activated Kupffer cells.

  1985cites this paper
• Mechanisms of Liver Cell Injury in Acute and Chronic Hepatitis B

  1984cites this paper
• Lymphocyte cytotoxicity for autologous hepatocytes.

  1984cites this paper
• Characterization of the mononuclear cell infiltrate in piecemeal necrosis.

  1984cites this paper
• Autoimmunity in liver disease.

  1984cites this paper
• The Specificity of Human Liver Membrane Lipoprotein: Studies with Monoclonal Antibodies

  1984cites this paper
• [Immunopathological mechanisms responsible for hepatic lesions caused by B virus].

  1984cites this paper
• Study of cellular immunity in experimental autoimmune hepatitis in mice.

  1984cites this paper
• Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis.

  1984cites this paper
• Modulation of the macrophage hepatocytotoxicity and plasminogen activator activity of activated macrophages from guinea pigs by serum components from normal human and patients with liver diseases.

  1983cites this paper
• Immunoregulatory T cells in HBV-induced chronic liver disease as defined by monoclonal antibodies.

  1983cites this paper
• Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae.

  1983cites this paper
• Induction of liver cell injury by antibody-dependent monocytemediated cytotoxicity in vitro

  1983cites this paper
• Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen.

  1983cites this paper
• T cell-mediated cytotoxicity against HBsAg-coated Chang cells in patients with chronic hepatitis: evidence for cytotoxicity mediated by delayed hypersensitivity T cell reaction.

  1982cites this paper
• Clinical evaluation of the liver cell membrane autoantibody assay.

  1982cites this paper
• [Chronic active hepatitis, specific antigens of the liver and lymphocytotoxicity].

  1982cites this paper
• The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis.

  1982cites this paper
• Cell-mediated cytotoxicity to rabbit liver-specific lipoprotein in chronic active hepatitis

  1982cites this paper
• A quantitative ultrastructural analysis of the leukocytes in contact with hepatocytes in chronic active hepatitis, with a cytochemical detection of mononuclear phagocytes.

  1982cites this paper
• Studies on ADCC assay using antigen-coated cells as target for detection of anti-LP-1 and anti-Tamm-Horsfall glycoprotein

  1982cites this paper
• Fractionation of the liver membrane lipoprotein (LSP) and characterisation of its antigenic determinants by autoantibodies and a heterologous anti-serum.

  1982cites this paper
• Studies on anti-LP-1 and anti-Tamm-Horsfall glycoprotein in chronic liver disease using ADCC assay against antigen-coated target cells.

  1982cites this paper
• A proposed role for the immune system in the pathogenesis of hepatitis B virus induced liver disease.

  1981cites this paper
• The Role of the Immune Response in the Pathogenesis of Primary Biliary Cirrhosis

  1981cites this paper
• Dynamics of cellular and humoral immunity to liver cell membrane antigens in acute viral hepatitis.

  1981cites this paper
• Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease.

  1981cites this paper
• Different mechanisms of "in vitro' lymphocytotoxicity against isolated rabbit hepatocytes during the course of acute viral hepatitis.

  1981cites this paper
• Spontaneous cell-mediated (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) in patients with acute and chronic active hepatitis

  1981cites this paper
• Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness.

  1981cites this paper
• Theimunopathogenesis of cronic HBV inducedliver disease

  1981cites this paper
• Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.

  1981cites this paper
• Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes.

  1980cites this paper
• Prophylaxis and treatment of viral hepatitis.

  1980cites this paper
• Joint report from "HLA--DR Intertransplant Workshop 79".

  1980cites this paper
• Liver-specific protein in perspective.

  1980cites this paper
• Immune response to rabbit liver-specific lipoprotein in acute viral hepatitis.

  1980cites this paper
• The role of liver membrane antigens as targets in autoimmune type liver disease

  1980cites this paper
• How specific is liver-specific protein?

  1980cites this paper
• Levamisole therapy for HBsAg-positive chronic liver disease.

  1980cites this paper
• Liver membrane antigen-targets of humoral and cell mediated immunity in chronic active hepatitis.

  1980cites this paper
• Immunologic effector mechanisms in hepatitis B-negative chronic active hepatitis

  1980cites this paper
• The liver specific protein: evidence for species-specific and non-species-specific determinants.

  1980cites this paper
• Lymphocyte cytotoxicity in human liver disease using rat hepatocyte monolayer cultures.

  1980cites this paper
• Immunological status as basis for appropriate treatment in subgroups of HBsAg-positive chronic hepatitis.

  1980cites this paper
• The nature of piecemeal necrosis in chronic active hepatitis.

  1979cites this paper
• Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.

  1979cites this paper
• LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?

  1979cites this paper
• Studies on "liver-specific" antigens. I. Evaluation of the liver specificity of "LSP" and "LP-2".

  1979cites this paper
• HLAandcell-mediated immunity inHB,Ag negative chronic active hepatitis1

  1979cites this paper
• Liver antigens in liver diseases. A review of recent developments and their clinical relevance.

  1979cites this paper
• Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.

  1979cites this paper
• [Chronic hepatitis: an immunological problem?].

  1979cites this paper
• Studies on "liver-specific" antigens. II. Detection of serum antibodies to liver and kidney cell membrane antigens in patients with chronic liver disease.

  1979cites this paper